Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allele Biotechnology has developed proprietary mRNA-based methods to generate clinical-grade iPSCs used in regenerative medicine and immuno-oncology. Its lead partnered program is in Phase 1 trials for type 1 diabetes. Other pipeline assets include preclinical therapies targeting eye disease, breast cancer (HER2), COVID‑19 vaccines, and inflammatory bowel disease. The company also provides CDMO services for cell therapies using its cGMP facility.[3][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allele Systems.